Acquisitions continue to drive OpenText, says Industrial Alliance

Ahead of its first quarter results OpenText (OpenText Stock Quote, Chart, News: TSX:OTC, Nasdaq:OTEX) is looking more or less fully valued but acquisitions could soon add considerable value to the company’s stock, says Industrial Alliance Securities analyst Blair Abernethy.

On Thursday, November 3, OpenText will report its Q1, 2017 results. The company is following on a fourth quarter in which it earned $0.71 on revenue of $484-million, a topline that was up 0.2 per cent over the same period a year prior.

“With our recent acquisitions, Release 16, EP Series, our enhancement packs, and Magellan, our next generation cognitive platform, we expect to grow our market share in Fiscal 2017,” said CEO Mark J. Barrenechea.

Abernethy says he expects OpenText will post Adjusted EPS of $0.90 on revenue of $480.6-million in the first quarter of 2017. The analyst says he will be focusing on certain data points next week.

“With the Q1 results, we will be keying in on signs of progress with recent acquisitions,” says Abernethy. “Recall that OpenText spent $315M in September to acquire HP’s Communication Management assets (estimated revenue of $110125M) and spent $163M on Recommind Inc. in late July (estimated revenue of $70-80M). We will also be watching for signs of traction with the recently released Suite 16 upgrade.”

In a research update to clients today, Abernethy maintained his “Buy” rating and one-year price target of (U.S.) $66.00 on OpenText, implying a return of just 1 per cent at the time of publication.

Abernethy says he will be watching the pending closing of OpenText’s Documentum purchase closely, as he believes that pickup alone could add between $7.00 and $9.00 to the company’s share price.

The analyst expects OpenText will earn $3.91 per share on revenue of $2.06-billion in fiscal 2017. He thinks these numbers will improve to earnings of $4.44 of a topline of $2.08-billion the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: OTC
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago